Puig-Molto, Marķa <br/><br/>
Impact of the EMA/FDA alerts on the use of effective contraceptive method in women of childbearing age undergoing valproic acid treatment in a long-stay psychiatric center.  [electronic resource] 

 -  Epilepsy & behavior : E&B  06 2020 
 - 107072 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-5069 
<br/><br/><label>Standard No.: </label>10.1016/j.yebeh.2020.107072  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anticonvulsants--therapeutic use<br/>Contraception--trends<br/>Drug Labeling--methods<br/>Drug and Narcotic Control--methods<br/>Epilepsy--drug therapy<br/>Europe--epidemiology<br/>Female<br/>Hospitals, Psychiatric--trends<br/>Humans<br/>Interrupted Time Series Analysis--methods<br/>Mental Disorders--drug therapy<br/>Middle Aged<br/>Retrospective Studies<br/>Spain--epidemiology<br/>Treatment Outcome<br/>Valproic Acid--therapeutic use<br/>Young Adult